FARMER BROS CO (FARM)

US3076751086 - Common Stock

1.8  +0.01 (+0.56%)

After market: 1.8001 +0 (+0.01%)

Fundamental Rating

1

Overall FARM gets a fundamental rating of 1 out of 10. We evaluated FARM against 90 industry peers in the Food Products industry. Both the profitability and financial health of FARM have multiple concerns. FARM is valued expensive and it does not seem to be growing.



1

1. Profitability

1.1 Basic Checks

FARM had negative earnings in the past year.
In the past year FARM has reported a negative cash flow from operations.
FARM had negative earnings in each of the past 5 years.
FARM had negative operating cash flow in 4 of the past 5 years.

1.2 Ratios

FARM has a worse Return On Assets (-4.16%) than 77.38% of its industry peers.
FARM's Return On Equity of -18.50% is on the low side compared to the rest of the industry. FARM is outperformed by 77.38% of its industry peers.
Industry RankSector Rank
ROA -4.16%
ROE -18.5%
ROIC N/A
ROA(3y)-16.31%
ROA(5y)-14.19%
ROE(3y)-77.32%
ROE(5y)-61.13%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

FARM has a Gross Margin of 40.79%. This is amongst the best in the industry. FARM outperforms 92.86% of its industry peers.
In the last couple of years the Gross Margin of FARM has grown nicely.
FARM does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 40.79%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.38%
GM growth 5Y5.49%

1

2. Health

2.1 Basic Checks

FARM does not have a ROIC to compare to the WACC, probably because it is not profitable.
FARM has more shares outstanding than it did 1 year ago.
The number of shares outstanding for FARM has been increased compared to 5 years ago.
FARM has a worse debt/assets ratio than last year.

2.2 Solvency

Based on the Altman-Z score of 1.74, we must say that FARM is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of FARM (1.74) is worse than 61.90% of its industry peers.
A Debt/Equity ratio of 0.57 indicates that FARM is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.57, FARM perfoms like the industry average, outperforming 45.24% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.57
Debt/FCF N/A
Altman-Z 1.74
ROIC/WACCN/A
WACC9.28%

2.3 Liquidity

FARM has a Current Ratio of 1.32. This is a normal value and indicates that FARM is financially healthy and should not expect problems in meeting its short term obligations.
FARM's Current ratio of 1.32 is in line compared to the rest of the industry. FARM outperforms 40.48% of its industry peers.
FARM has a Quick Ratio of 1.32. This is a bad value and indicates that FARM is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of FARM (0.58) is worse than 70.24% of its industry peers.
Industry RankSector Rank
Current Ratio 1.32
Quick Ratio 0.58

2

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 90.24% over the past year.
The Revenue has been growing slightly by 0.66% in the past year.
The Revenue for FARM have been decreasing by -10.56% on average. This is quite bad
EPS 1Y (TTM)90.24%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-300%
Revenue 1Y (TTM)0.66%
Revenue growth 3Y9.21%
Revenue growth 5Y-10.56%
Sales Q2Q%3.88%

3.2 Future

Based on estimates for the next years, FARM will show a very negative growth in Earnings Per Share. The EPS will decrease by -24.83% on average per year.
FARM is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.94% yearly.
EPS Next Y-220.17%
EPS Next 2Y-24.83%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year4.19%
Revenue Next 2Y4.94%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

0

4. Valuation

4.1 Price/Earnings Ratio

FARM reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year FARM is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

FARM's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. FARM is more expensive than 70.24% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 501.56

4.3 Compensation for Growth

FARM's earnings are expected to decrease with -24.83% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-24.83%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for FARM!.
Industry RankSector Rank
Dividend Yield N/A

FARMER BROS CO

NASDAQ:FARM (1/3/2025, 8:00:02 PM)

After market: 1.8001 +0 (+0.01%)

1.8

+0.01 (+0.56%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)11-07 2024-11-07/amc
Earnings (Next)02-06 2025-02-06
Inst Owners41.84%
Inst Owner Change0.66%
Ins Owners7.4%
Ins Owner Change11.6%
Market Cap38.43M
Analysts82.5
Price Target5.36 (197.78%)
Short Float %0.31%
Short Ratio0.56
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)11.04%
Min EPS beat(2)1.96%
Max EPS beat(2)20.12%
EPS beat(4)4
Avg EPS beat(4)66.1%
Min EPS beat(4)1.96%
Max EPS beat(4)160.69%
EPS beat(8)5
Avg EPS beat(8)0.26%
EPS beat(12)7
Avg EPS beat(12)3.37%
EPS beat(16)8
Avg EPS beat(16)-41.2%
Revenue beat(2)1
Avg Revenue beat(2)0.12%
Min Revenue beat(2)-0.83%
Max Revenue beat(2)1.06%
Revenue beat(4)1
Avg Revenue beat(4)-1.53%
Min Revenue beat(4)-5.44%
Max Revenue beat(4)1.06%
Revenue beat(8)2
Avg Revenue beat(8)2.48%
Revenue beat(12)4
Avg Revenue beat(12)-11.75%
Revenue beat(16)5
Avg Revenue beat(16)-18.33%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)6.61%
EPS NY rev (3m)2.59%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.01%
Revenue NY rev (3m)0.6%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.11
P/FCF N/A
P/OCF N/A
P/B 0.94
P/tB 1.27
EV/EBITDA 501.56
EPS(TTM)-0.36
EYN/A
EPS(NY)-0.28
Fwd EYN/A
FCF(TTM)-0.85
FCFYN/A
OCF(TTM)-0.21
OCFYN/A
SpS16.13
BVpS1.92
TBVpS1.42
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -4.16%
ROE -18.5%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 40.79%
FCFM N/A
ROA(3y)-16.31%
ROA(5y)-14.19%
ROE(3y)-77.32%
ROE(5y)-61.13%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.38%
GM growth 5Y5.49%
F-Score4
Asset Turnover1.89
Health
Industry RankSector Rank
Debt/Equity 0.57
Debt/FCF N/A
Debt/EBITDA 199.5
Cap/Depr 118.45%
Cap/Sales 3.97%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.32
Quick Ratio 0.58
Altman-Z 1.74
F-Score4
WACC9.28%
ROIC/WACCN/A
Cap/Depr(3y)83.63%
Cap/Depr(5y)72.87%
Cap/Sales(3y)4.43%
Cap/Sales(5y)4.51%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)90.24%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-300%
EPS Next Y-220.17%
EPS Next 2Y-24.83%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)0.66%
Revenue growth 3Y9.21%
Revenue growth 5Y-10.56%
Sales Q2Q%3.88%
Revenue Next Year4.19%
Revenue Next 2Y4.94%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y57.71%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year430.49%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y46.13%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y75.1%
OCF growth 3YN/A
OCF growth 5YN/A